// App-Quantinova.ai

: Gene Editing of BTK in Acute Myeloid Leukaemia Using CRISPR-Cas9

Researchers

Presenter

  • Melanie Maerken

Principal Investigators

  • David MacEwan

  • Nicholas Harper

  • Joseph R Slupsky

  • Adam Linley

Medical Centers

  • Department of Cellular and Molecular Physiology, University of Liverpool, Liverpool, United Kingdom

  • Department of Cellular and Molecular Physiology, University of Liverpool, Liverpool, United Kingdom

  • Depts of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

  • B cell lymphomas

  • Hematology-oncology disease

  • Solid malignancies

Biomarkers

  • GATA Binding Protein 3

Drug/Treatment

  • Ibrutinib

  • Cysteine Hydrochloride

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved